CC

Casdin Capital Portfolio holdings

AUM $1.1B
This Quarter Return
+25.17%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
AUM
$1.34B
AUM Growth
+$1.34B
Cap. Flow
+$217M
Cap. Flow %
16.15%
Top 10 Hldgs %
71.54%
Holding
39
New
3
Increased
13
Reduced
4
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CDXS icon
26
Codexis
CDXS
$226M
$6.98M 0.52%
2,000,000
ABSI icon
27
Absci
ABSI
$351M
$5.53M 0.41%
973,260
PACB icon
28
Pacific Biosciences
PACB
$384M
$3.88M 0.29%
1,035,859
KYTX icon
29
Kyverna Therapeutics
KYTX
$156M
$3.73M 0.28%
+150,000
New +$3.73M
GLUE icon
30
Monte Rosa Therapeutics
GLUE
$304M
$3.6M 0.27%
510,882
SNDX icon
31
Syndax Pharmaceuticals
SNDX
$1.4B
$3.57M 0.27%
150,000
PRME icon
32
Prime Medicine
PRME
$562M
$2.57M 0.19%
367,175
DNA icon
33
Ginkgo Bioworks
DNA
$665M
$1.69M 0.13%
+1,459,747
New +$1.69M
EXAI
34
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$1.22M 0.09%
213,900
OMIC
35
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$681K 0.05%
1,323,885
KRON
36
DELISTED
Kronos Bio
KRON
$161K 0.01%
123,839
LIAN
37
DELISTED
LianBio American Depositary Shares
LIAN
-206,415
Closed -$923K
SLGC
38
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
-12,604,275
Closed -$31.9M
FATE icon
39
Fate Therapeutics
FATE
$119M
-2,050,000
Closed -$7.67M